Skip to the answer

Desonide

Desonide is a low-potency topical corticosteroid (steroid) used on the skin to relieve inflammation and itching from steroid-responsive skin conditions, and to treat mild to moderate atopic dermatitis (eczema) in the gel form.

Brand names TridesilonDesowenLokaraVerdesoTridesilon Cream
Drug class Corticosteroid
Rx Form 1
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026 Content updated Oct 2, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 25 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

✓No current FDA shortage listed · checked Oct 6, 2026
Other forms & routes:
Topical
Desonide at a glance The quick version — the full detail is in the Patient Information Guide below.
Dr. Brian Staiger, PharmD, BCPS
The Pharmacist’s Take By · Clinical pharmacist · Written

Desonide is a low-potency steroid that calms skin inflammation and itching, and its gel treats mild to moderate atopic dermatitis (eczema) from age 3 months; around since about 1983 and available generically, it is a familiar choice for the face and children. Most people tolerate it well, noticing at most burning, itching or dryness where it goes on. Overuse is the risk, as it can thin skin, so use a thin layer for the shortest time and stay within your product’s limit (two weeks for cream or ointment, four for gel). Check with your prescriber if it isn’t working by then or you’re treating a child or large areas.

Clinical pearls

  • Ointment is greasier and suits dry, cracked patches, while cream or gel spreads more easily on the face and hairy skin.
  • Never cover treated skin with tight bandages, plastic wrap or snug diapers, because sealing it in boosts steroid absorption.
  • Mention any other steroid you use, cream, inhaler or tablet, since total steroid exposure adds up across products.
  • A rash that starts oozing, crusting or spreading may be infected, and desonide will not fix that without separate treatment.
How we write & review this content — our editorial policy →
How you get itPrescription only
Comes asTopical cream, ointment or gel
Earliest FDA record1972
Companies listing it with the FDA15
FDA label last updatedSep 8, 2025
FDA’s strongest warning (boxed)None on the label

Patient information guide A plain-language walkthrough of Desonide, written from its FDA label.

What Desonide is used for

▾

Desonide is used on the skin for the following, depending on the product:

  • Desonide cream, ointment and lotion: relief of inflammation and itching from corticosteroid-responsive dermatoses.
  • Desonide Gel, 0.05%: mild to moderate atopic dermatitis in people 3 months and older.
  • Cream and ointment, 0.05%: not to be used longer than two weeks unless a doctor directs it.

How Desonide works

▾

Desonide is a corticosteroid with anti-inflammatory, anti-itch and blood-vessel-narrowing effects. Steroids are thought to trigger proteins that block the release of arachidonic acid. That slows production of inflammation chemicals like prostaglandins and leukotrienes.

The exact mechanism is not fully understood.

Desonide dosage

▾

Desonide is applied only to the skin, as a thin layer or film. Stop when the skin is controlled.

  • Desonide Gel, 0.05%: twice daily, rubbed in gently, for no more than 4 consecutive weeks.
  • Cream or ointment, 0.05%: two to four times daily depending on severity.
  • Cream or lotion products: two or three times daily. Shake the lotion well.
  • Do not use with occlusive dressings. Avoid eyes and mucous membranes (gel is not for oral, eye or vaginal use).

Follow your prescriber and product label.

Dosing details from the FDA-approved label

From the Desonide prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.

  • Desonide gel (Topical Gel)
    • Apply a thin layer to the affected areas two times daily and rub in gently
    • Discontinue use when control is achieved
    • Maximum: Treatment beyond 4 consecutive weeks is not recommended.
    • If no improvement is seen within 4 weeks, reassessment of diagnosis may be necessary. Do not use with occlusive dressings.
  • Desonide cream 0.05% or ointment 0.05%
    • Apply to the affected area as a thin film two to four times daily depending on the severity of the condition
    • Therapy should be discontinued when control is achieved
    • If no improvement is seen within two weeks, reassessment of diagnosis may be necessary. Do not use with occlusive dressings.
  • Desonide cream or lotion
    • Apply to the affected areas as a thin film two or three times daily depending on the severity of the condition
    • Shake lotion well before using
    • Therapy should be discontinued when control is achieved
    • If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Do not use with occlusive dressings.
  • Desonide ointment USP, 0.05%
    • Apply to the affected area as a thin film from two to four times daily depending on the severity of the condition
    • Therapy should be discontinued when control is achieved
    • If no improvement is seen within two weeks, reassessment of diagnosis may be necessary. Do not use with occlusive dressings.
Read the label’s full dosing text

2 DOSAGE AND ADMINISTRATION Apply a thin layer to the affected areas two times daily and rub in gently. Discontinue use when control is achieved. If no improvement is seen within 4 weeks, reassessment of diagnosis may be necessary. Treatment beyond 4 consecutive weeks is not recommended. Do not use with occlusive dressings. Avoid contact with eyes or other mucous membranes. For topical use only. Not for oral, ophthalmic, or intravaginal use. • Apply as a thin layer to the affected areas two times daily and rub in gently. ( 2 ) • Therapy should be discontinued when control is achieved. ( 2 ) • If no improvement is seen within 4 weeks, reassessment of diagnosis may be necessary. ( 2 ) • Should not be used with occlusive dressings. ( 2 ) • Treatment beyond 4 consecutive weeks is not recommended. ( 2 ) • For topical use only. Not for oral, ophthalmic, or intravaginal use. ( 2 )

Read the full Dosage and Administration section on DailyMed →

Desonide side effects

▾

Side effects are mostly local to the skin.

Common side effects

  • Burning where applied
  • Rash
  • Itching at the application site
  • Skin irritation
  • Dryness
  • Acne-like bumps
  • Acne-like bumps or inflamed hair follicles
  • Lighter patches of skin

When to get medical help

  • Call your doctor if your skin gets worse, shows no improvement within the time stated for your product (4 weeks for the gel, 2 weeks for the cream, ointment or lotion), or becomes more irritated.
  • Call your doctor if you develop signs of a skin infection while using it.
  • Tell your doctor about signs that steroid is being absorbed into the body, such as Cushing’s syndrome (a hormone problem from too much steroid) or adrenal suppression.
  • In children, report headaches, bulging soft spots on an infant’s head, slowed growth or delayed weight gain.
  • Stop using it and call your doctor if you think you are having an allergic reaction to it, such as a rash that does not heal.

Contact your doctor if you notice skin thinning, stretch marks, signs of infection, worsening irritation, or signs of steroid absorption into the body.

Desonide warnings and precautions

▾
  • Absorption into the body: can suppress the adrenal glands, cause Cushing’s syndrome, raise blood sugar and unmask diabetes.
  • Higher risk with: large areas, long use, covered use, damaged skin, liver failure and use in children.
  • Skin effects: thinning, stretch marks, irritation, and allergic contact dermatitis. Some may be irreversible.
  • Infections: a skin infection needs its own treatment, and the steroid may need to be stopped until it is controlled.
  • Irritation: stop the medicine if irritation develops.

Desonide interactions

▾

The label points to one main caution.

  • Other corticosteroid-containing products: using more than one at a time may increase total steroid exposure in the body.

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Check Desonide against a supplement or herb →

Before taking Desonide

▾
  • Do not use if you are allergic to any ingredient in the product.
  • The gel is not recommended under 3 months of age.
  • Children are more prone to steroid absorption effects, including slowed growth and raised pressure inside the head.
  • Pregnancy: use the gel only if the benefit justifies the risk to the baby.
  • Breastfeeding: use caution and talk with your doctor.
  • Older adults: consider liver, kidney and heart function and other medicines.

Desonide overdose

▾

Desonide cream and ointment applied to the skin can be absorbed enough to cause effects throughout the body. Use only as directed and contact your doctor or poison control if you think too much was used.

What Desonide does in the body

▾

In a study of children 6 months to 6 years old with widespread moderate to severe atopic dermatitis, 1 of 37 (3%) showed adrenal gland suppression after 4 weeks of using Desonide Gel, 0.05%. It was not checked afterward, so it is unknown whether it reversed.

How your body processes Desonide

▾

How much steroid is absorbed through the skin depends on many factors, including the product base and the skin barrier. Topical steroids can be absorbed through normal skin. Inflamed or diseased skin may absorb more. Desonide cream and ointment are in the low range of potency compared with other topical steroids.

How to store Desonide

▾

Store between 2° and 30°C (36° and 86°F).

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →

Desonide: pharmacist answers to common questions

Quick, plain-English answers to the questions patients ask most about Desonide — the kind of thing our pharmacy team would talk through with you at the counter.

What is desonide used for?

▾
It calms inflammation and itching from skin conditions that respond to steroids. The gel is specifically for mild to moderate eczema (atopic dermatitis) in people 3 months and older.

How do I apply it?

▾
Put a thin layer on the affected skin and rub it in gently. How many times a day depends on your product, so follow your label and prescriber. Don’t cover the area with tight wraps, and keep it out of your eyes.

How long can I use it?

▾
Use it for the shortest time that works. The gel should not go past 4 weeks in a row. The cream and ointment should not go past two weeks unless your doctor says so. Stop once your skin is under control.

What side effects should I expect?

▾
Mild burning, rash, itching, dryness or irritation where you apply it. Call your doctor if the skin gets worse, thins, looks infected, or if you notice signs of too much steroid in the body.

Is it safe for my child?

▾
The gel is for children 3 months and older. Children absorb more steroid through the skin than adults, so use the least amount for the shortest time and watch for slowed growth or headaches. Check with your child’s doctor first.

Can I use it if I’m pregnant or breastfeeding?

▾
Talk to your doctor first. In pregnancy, the gel should be used only if the benefit outweighs the possible risk to the baby. If you’re breastfeeding, caution is advised.

Is Desonide available over the counter?

▾
No. Desonide is a prescription medicine: every Desonide product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was Desonide first available?

▾
The earliest FDA record we hold for Desonide is from 1972: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when Desonide was first used.

Who makes Desonide?

▾
15 companies currently list Desonide products in the FDA's NDC Directory, including Bryant Ranch Prepack, Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Limited. That count includes repackagers and distributors as well as manufacturers (companies that sell only the raw ingredient are not counted), so fewer companies actually make it; the label on your bottle names the one that supplied yours.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →

More about Desonide on HelloPharmacist

🌿Drug & Supplement CheckerDesonide vs. vitamins & herbs 💬Ask a PharmacistFree answer, usually < 24h 🔎NDC & pricing lookupFind Desonide NDCs & costs 🅰️Browse Drugs A–ZLook up any medication
Detailed data & references for Desonide Forms & strengths, pricing, billing codes, manufacturers, safety reports and sourcing — the data behind the page. Most people can stop here. Each section below opens on a tap.

Desonide forms and strengths (how it comes)

Desonide is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Desonide inactive ingredients by manufacturer.

Topical cream, ointment or gel

By mouth · On the skin
Brands Tridesilon Cream
How this form is used
What it may be used for
  • Desonide Gel, 0.05% treats mild to moderate atopic dermatitis in people 3 months and older.
  • Desonide cream and ointment, 0.05% relieve inflammation and itching from corticosteroid-responsive skin conditions.
Important instructions
  • Desonide Gel, 0.05% is applied as a thin layer twice daily and not used beyond 4 consecutive weeks.
  • Desonide cream and ointment, 0.05% are applied as a thin film two to four times daily, depending on severity.
  • Desonide products should not be used with occlusive dressings.
Available strengths 4 strengths
0.5 mg/g 0.5 mg/mL 0.03 g/60 g 1 kg/kg
49 FDA-listed product records ⓘ

Desonide on the U.S. market: products, makers and brands

How Desonide appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

15 companies list 25 Desonide product records with the FDA, mostly as topical cream, ointment or gel; the earliest marketing or approval year on record is 1972. Brand names on the directory include Tridesilon, Desowen, Lokara and 2 more; the rest are generics.

1
Dose forms ⓘ
15
Labelers (makers, repackagers, distributors)
2
Brand names
25
FDA-listed product records ⓘ
1972
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Powder (9) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

Bryant Ranch Prepack16%
Alembic Pharmaceuticals Inc.12%
Alembic Pharmaceuticals Limited12%
Advanced Rx of Tennessee, LLC8%
Northstar Rx Llc8%
Sun Pharmaceutical Industries, Inc.8%
Other makers36%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How widely Desonide is used (Medicaid data)

A general measure of how commonly Desonide is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Desonide is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

133,862
Medicaid prescriptions filled (Q1–Q4 2025)
$3.6M gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Desonide prescribed? Of the 1,601 medications we measure, Desonide ranks #464 by Medicaid prescriptions — more than 71% of them.

Where Desonide ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5
Total prescriptions — #464 of 1,601
#459 Lubiprostone 135,857 Rx #460 Hydroxyurea 135,027 Rx #461 Leucovorin 134,894 Rx #462 Ranolazine 134,744 Rx #463 Dextromethorphan and B... 134,150 Rx #464 Desonide Topical 133,862 Rx #465 Desonide 133,862 Rx #466 Liothyronine 133,453 Rx #467 Dextroamphetamine 132,973 Rx #468 Epinephrine / Lidocain... 132,083 Rx #469 Tranexamic Acid 131,595 Rx

Utilization by Desonide product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 0.5 mg/mL topical cream is the most-dispensed Desonide product — about 51% of these Medicaid prescriptions.

desonide 0.5 MG/ML Topical Cream Most dispensed

68,821 Medicaid prescriptions (Q1–Q4 2025) 51% of Desonide prescriptions shown $1.8M gross reimbursement (before rebates) ≈ $26 per prescription (gross)

Summed across the 12 of 29 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 349351

desonide 0.0005 MG/MG Topical Ointment

62,624 Medicaid prescriptions (Q1–Q4 2025) 47% of Desonide prescriptions shown $1.7M gross reimbursement (before rebates) ≈ $27 per prescription (gross)

Summed across the 10 of 26 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 204135

desonide 0.5 MG/ML Topical Lotion

2,417 Medicaid prescriptions (Q1–Q4 2025) 2% of Desonide prescriptions shown $159,245 gross reimbursement (before rebates) ≈ $66 per prescription (gross)

Summed across the 6 of 15 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197572

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Desonide, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 28 of 70 listed Desonide NDCs with Medicaid activity.

Compare Desonide products

A representative set of FDA-listed product records for Desonide — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 25 of 25 products — FDA National Drug Code Directory. See every product, package size and price: browse all 25 Desonide NDCs →

Desonide side effects reported to the FDA (FAERS)

After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Desonide — a signal of what to watch for, not proof the drug caused it.

The effects most often named in FDA reports that mention Desonide are macular degeneration, pain, nausea; about 55% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.

4,960
Reports mentioning it
55%
Reported as serious
12
Distinct effects shown
Most reported effects
Macular Degeneration
787
Pain
392
Nausea
376
Pruritus
345
Rash
327
Headache
322
Erythema
316
Pyrexia
307
Psoriasis
284
Malaise
282
Age groups
Adult · 797Elderly · 385Child · 146Adolescent · 119Infant · 11

Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Desonide in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.

Desonide FDA approval history

How Desonide went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.

Desonide was first approved by the FDA in 1972 (Brand: DESONIDE · Padagis Us); the first generic version was approved in 1988. It remains available in U.S. pharmacies today.

1972
Brand approved
Brand: DESONIDE · Padagis Us
1988
First generic approved
Lower-cost ANDA competition begins
2026
Available today
Active in U.S. pharmacies

Source: Drugs@FDA.

Desonide recall history

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Desonide recalls since July 2021.

✅No Desonide recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.

Ingredient (IN) Desonide RxCUI 3254 6 dose forms · 6 strengths
  1. Dose form (SCDF) Otic Solution RxCUI 654357 No current FDA listing
    Clinical drug / strength (SCD) 0.5 MG/ML RxCUI 654358
  2. Dose form (SCDF) Topical Cream RxCUI 377668 In current FDA listings
    Clinical drug / strength (SCD) 0.5 MG/ML RxCUI 349351
  3. Dose form (SCDF) Topical Foam RxCUI 668349 In current FDA listings
    Clinical drug / strength (SCD) 0.5 MG/ML RxCUI 668350
  4. Dose form (SCDF) Topical Gel RxCUI 438864 In current FDA listings
    Clinical drug / strength (SCD) 0.0005 MG/MG RxCUI 669081
  5. Dose form (SCDF) Topical Lotion RxCUI 378605 In current FDA listings
    Clinical drug / strength (SCD) 0.5 MG/ML RxCUI 197572
  6. Dose form (SCDF) Topical Ointment RxCUI 378983 In current FDA listings
    Clinical drug / strength (SCD) 0.0005 MG/MG RxCUI 204135

Look up RxCUI 3254 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

💵 What Desonide costs pharmacies (NADAC benchmark)

The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.

FormStrengthPharmacy acquisition benchmark
Cream · Topical 0.5 mg/g $0.197–$0.306 per gram NDC details & price history
Lotion · Topical 0.5 mg/mL $0.525–$0.540 per mL NDC details & price history
Ointment · Topical 0.5 mg/g $0.257–$0.392 per gram NDC details & price history
Why show this? Your out-of-pocket cost depends on insurance, pharmacy markup, and discounts — but the acquisition benchmark tells you whether the medication itself is inexpensive or costly, which strengths cost more per dose, and whether a cash-price quote is in a reasonable range. Each row links to the NDC-level record with its full price history.

Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.

Desonide brand names

Desonide is sold under 5 brand names in the FDA directory — Tridesilon, Desowen, Lokara, Verdeso and others. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.

Tridesilon Desowen Lokara Verdeso Tridesilon Cream

Who makes Desonide: manufacturers and labelers

15 companies list Desonide products with the FDA. By number of product records, the largest are Bryant Ranch Prepack, Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Limited. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Bryant Ranch Prepack 4 Alembic Pharmaceuticals Inc. 3 Alembic Pharmaceuticals Limited 3 Advanced Rx of Tennessee, LLC 2 Northstar Rx Llc 2 Sun Pharmaceutical Industries, Inc. 2 Actavis Pharma, Inc. 1 Cintex Services, LLC 1 Cosette Pharmaceuticals, Inc. 1 Encore Dermatology Inc 1 Padagis Israel Pharmaceuticals Ltd 1 Proficient Rx LP 1 Taro Pharmaceuticals U.S.A., Inc. 1 Viona Pharmaceuticals Inc 1 Zydus Lifesciences Limited 1

Desonide drug class (RxNorm)

Desonide belongs to the Corticosteroid class.

Pharmacologic class Corticosteroid
Drug family (ATC) Corticosteroids, moderately potent (group II), Corticosteroids, plain
How it works Corticosteroid Hormone Receptor Agonists

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

Sources for this Desonide page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Sep 8, 2025
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Desonide.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Desonide after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
25
Finished products in the current FDA directory
25
Companies listing them (makers, repackagers, distributors)
15
FDA labeler codes behind them ⓘ
16
Linked representative label ⓘ
Actavis Pharma, Inc.
Linked label effective
Sep 8, 2025
Composite sections available
21
Linked SPL Set ID
ff5d4cd8-ab4d-4a9e-b84b-445c81eeea99
Linked SPL Document ID
f3953b9e-138f-4d86-8eea-0fc03c3c2747
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Actavis Pharma, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →